| Literature DB >> 30132276 |
Amelia Pietropaolo1, Patrick Jones1, Lily Whitehurst1, Bhaskar K Somani2,3.
Abstract
Ureteroscopy and laser stone fragmentation (URSL) has had recent advancements with the more powerful laser systems with the ability to 'dust' and 'pop-dust' the stone. We wanted to look at the outcomes of this method for large stones (≥ 15 mm) using our new 100 W holmium laser. Over a period of 16 months (January 2017-April 2018), 50 patients underwent URSL for minimum cumulative stone size of ≥ 15 mm. Data were collected prospectively on patient and stone demographics and outcomes of URSL. The laser setting used was a power of 0.3-0.6 J and a frequency of 20-50 Hz using a long-pulse setting with a 272-µm fiber. Fifty patients underwent 55 URSL procedures (5 bilateral procedures) using dusting and pop-dusting settings. The mean age was 58 years (range 2-88 years) with a male:female ratio of 35:15. The mean single and overall stone size were 10.3 mm (3-23 mm) and 21 mm (range 15-52 mm) with two-thirds of all patients (65%) having multiple stones. The stone location was in the kidney (n = 65, 78%), in the ureter (n = 19, 22%) and 5 patients had bilateral renal stones. With a mean operating time of 51 min, the initial and final SFR were 93 and 98%, respectively. A pre-operative stent, access sheath and a post-operative stent were present in 29 (53%), 34 (62%) and 51 (93%) procedures, respectively. Over a mean hospital stay of 0.6 days (74% day-case procedures), there was one Clavien IV complication related to urosepsis but without any other major or minor complications. Dusting and pop-dusting techniques achieve an excellent SFR with low risk of complications even for large stones. This might set a new benchmark for treating large stones, bilateral or multiple stones in a single setting, without the need for secondary procedures in most cases.Entities:
Keywords: Dusting; Fragmentation; Laser; Pop-dusting; Popcorn; Stone; Ureteroscopy
Year: 2018 PMID: 30132276 PMCID: PMC6647176 DOI: 10.1007/s00240-018-1076-4
Source DB: PubMed Journal: Urolithiasis ISSN: 2194-7228 Impact factor: 3.436
Patient demographics and overall outcomes of the study
| Patient demographics and clinical data (patients | |
|---|---|
| Male:female ( | 35:15 |
| Mean age, years (range) | 58 (2–88) |
| Stone size (cumulative) in mm | 21 (range 15–52 mm) |
|
| |
| Lower calyx | 34 |
| Renal pelvis | 15 |
| Upper calyx | 11 |
| Middle calyx | 5 |
| Pelvi-ureteric junction | 4 |
| Ureter | 15 |
| (Multiple bilateral kidney stones) | (36) |
| (Multiple kidney + ureter) | (19) |
| Access sheath (%) | (62%) |
| Size | |
| 9.5/11.5 | 6 |
| 12/14 | 26 |
| 14/16 | 2 |
| Pre-operative stent, | 25 (45%) |
| Post-operative stent placement, | 51 (93%) |
| Mean hospital stay (range) | 0.6 days (0–7) |
| Complications | 1 (Clavien IV) (Urosepsis, ICU admission) |
| Stone-free rate, | Initial 93% Final 98% (1.1 ± 0.27 procedure per patient) |
|
| |
| Calcium oxalate monohydrate | 11 |
| Calcium phosphate carbonate | 2 |
| Calcium oxalate dihydrate + calcium oxalate monohydrate | 4 |
| Magnesium ammonium phosphate hexahydrate + calcium phosphate carbonate | 7 |
| Calcium oxalate monohydrate + calcium phosphate carbonate | 7 |
| Calcium oxalate dihydrate + calcium oxalate monohydrate + calcium phosphate carbonate | 5 |
| Calcium hydrogen phosphate dihydrate | 1 |
| Magnesium ammonium phosphate | 3 |
| Cystine | 3 |
| Uric acid | 7 |